Results 161 to 170 of about 38,526 (184)

Bortezomib

Reactions Weekly, 2015
  +4 more sources

Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial

Lancet Oncology, The, 2021
Phillipe Moreau, Bertrand Arnulf, Marie Christine Béné   +2 more
exaly  

Chemotherapy‐induced peripheral neurotoxicity: A critical analysis

Ca-A Cancer Journal for Clinicians, 2013
Susanna B Park, David Goldstein, Martin Koltzenburg   +2 more
exaly  

Bortezomib

Reactions Weekly
  +4 more sources

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial

Lancet Oncology, The, 2020
Shaji K Kumar, Simon J Harrison, Michele Cavo   +2 more
exaly  

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Lancet, The, 2019
Phillipe Moreau, Michel M Attal, `Cyrille Hulin   +2 more
exaly  

A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance

Cancer Cell, 2012
Bin Zhou, Mikael Altun, Benedikt M. Kessler   +2 more
exaly  

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

Cancer Cell, 2005
Klaus Podar, Constantine Mitsiades, Hiroshi Yasui   +2 more
exaly  

Bortezomib

Reactions Weekly, 2014
openaire   +1 more source

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

Lancet, The, 2017
Muneer H Abidi, S Vincent Rajkumar, Robert Z Orlowski   +2 more
exaly